Moonlake Immunotherapeutics Stock Filter Stocks by Fundamentals
| MLTX Stock | USD 41.76 0.01 0.02% |
MoonLake Immunotherapeutics fundamentals help investors to digest information that contributes to MoonLake Immunotherapeuti's financial success or failures. It also enables traders to predict the movement of MoonLake Stock. The fundamental analysis module provides a way to measure MoonLake Immunotherapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MoonLake Immunotherapeuti stock.
MoonLake |
Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
MoonLake Fundamentals
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.18 | ||||
| Current Valuation | 2.2 B | ||||
| Shares Outstanding | 63.28 M | ||||
| Shares Owned By Insiders | 15.22 % | ||||
| Shares Owned By Institutions | 84.78 % | ||||
| Number Of Shares Shorted | 8.05 M | ||||
| Price To Book | 5.93 X | ||||
| EBITDA | (141.71 M) | ||||
| Net Income | (121.24 B) | ||||
| Cash And Equivalents | 92.71 M | ||||
| Cash Per Share | 2.51 X | ||||
| Total Debt | 2.83 B | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 25.51 X | ||||
| Book Value Per Share | 7.08 X | ||||
| Cash Flow From Operations | (116.59 B) | ||||
| Short Ratio | 17.54 X | ||||
| Earnings Per Share | (1.89) X | ||||
| Target Price | 78.67 | ||||
| Number Of Employees | 11 | ||||
| Beta | 1.28 | ||||
| Market Capitalization | 2.64 B | ||||
| Total Asset | 477.93 B | ||||
| Retained Earnings | (235.59 B) | ||||
| Working Capital | 451.82 M | ||||
| Net Asset | 477.93 B |
About MoonLake Immunotherapeuti Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MoonLake Immunotherapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MoonLake Immunotherapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MoonLake Immunotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MoonLake Stock Analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.